Clinical Trial Update: Levetiracetam in Central Pain in Multiple Sclerosis(MS) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating levetiracetam for central pain in people with multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Odense University Hospital | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED